- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diabetic Foot in Sweden
Total 530 results
-
AstraZenecaOptum, Inc.Completed
-
Imcyse SAActive, not recruitingDiabetes Mellitus, Type 1United Kingdom, United States, Australia, Lithuania, Belgium, Italy, Slovenia, Sweden
-
Health Information Management, BelgiumUnknownDiabetes Mellitus | Chronic Obstructive Pulmonary Disease | Chronic Heart FailureDenmark, Estonia, Germany, Italy, Spain, Sweden
-
AstraZenecaCompletedDiabetes Mellitus Type 2United States, Australia, Canada, Denmark, Finland, Germany, Israel, Italy, Japan, Korea, Republic of, Norway, Portugal, Singapore, Spain, Sweden, Taiwan, United Kingdom
-
SanofiCompletedDiabetes Mellitus, Type 1Belgium, France, Netherlands, Sweden
-
AstraZenecaCompletedDiabetes Mellitus, Type 2 | Exocrine Pancreatic InsufficiencySweden, Poland, Latvia, Denmark, Hungary, Slovakia
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusSweden, Germany, Greece, Denmark, France
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Poland, Russian Federation, Germany, Italy, Netherlands, Spain, Sweden, Argentina, Denmark, Finland, Hungary, Norway, Colombia, Austria, Greece, Puerto Rico
-
Aimmune Therapeutics, Inc.CompletedPeanut AllergyUnited States, Spain, Ireland, Netherlands, Canada, United Kingdom, Germany, Denmark, Italy, Sweden
-
Aimmune Therapeutics, Inc.CompletedPeanut AllergyUnited States, Spain, Netherlands, Italy, Canada, Germany, Ireland, Sweden, United Kingdom
-
SanofiTerminatedDiabetes Mellitus, Type 2United States, Romania, Russian Federation, Spain, Sweden, India, Mexico, Denmark, Finland, Hungary, Italy, Korea, Republic of, Chile, Puerto Rico
-
SanofiCompletedDiabetes Mellitus, Type 2France, Spain, Italy, Belgium, Germany, Poland, Portugal, Czech Republic, Slovakia, Australia, Netherlands, Sweden, United Kingdom, Switzerland, Romania
-
Marjukka KolehmainenLund University; Uppsala University; Aarhus University Hospital; University of... and other collaboratorsCompletedCardiovascular Diseases | Insulin Resistance | Type 2 Diabetes | Impaired Glucose Tolerance | Abdominal ObesitySweden, Denmark, Finland, Iceland, Norway
-
ITB-Med LLCRecruitingDiabetes Mellitus, Type 1Belgium, Spain, United Kingdom, Italy, Germany, Poland, France, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesDenmark, Sweden, Norway
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Poland, Mexico, Hungary, Spain, Romania, South Africa, Denmark, Czechia, Sweden
-
AlizymeCompletedObesity | Non-Insulin-Dependent Diabetes MellitusFinland, Netherlands, Denmark, United Kingdom, Sweden
-
SanofiCompletedDiabetes Mellitus, Type 2France, Korea, Republic of, Russian Federation, Spain, Italy, Belgium, Germany, Hungary, Ireland, Mexico, Poland, Taiwan, Turkey, Netherlands, Greece, Lithuania, Sweden, United Kingdom
-
BayerRecruitingVisual Impairment | Neovascular Age-related Macular Degeneration (nAMD) | Diabetic Macula Edema (DME)Germany, Canada, Denmark, France, Italy, Saudi Arabia, Switzerland, Australia, Finland, Netherlands, Sweden, Norway, United Arab Emirates, Japan, United Kingdom
-
SanofiCompletedDiabetes Mellitus, Type 1France, Australia, Spain, Sweden, United States, Austria, Hungary, Israel, Italy, United Kingdom, Korea, Republic of, Netherlands
-
SanofiRecruitingType 1 Diabetes MellitusBelgium, Spain, Canada, United States, Poland, France, Sweden, Denmark, Germany, Italy, United Kingdom, Hungary
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Romania, Slovakia, Israel, Saudi Arabia, India, Malaysia, Mexico, Russian Federation, Germany, Croatia, Poland, Serbia, Bulgaria, Canada, Slovenia, Sweden, Denmark, Hungary, Argentina, Austria, Finland, Lebanon, Czechia, Netherlands
-
Aimmune Therapeutics, Inc.CompletedPeanut AllergyUnited States, Canada, Spain, Netherlands, Germany, United Kingdom, Ireland, Sweden, France, Italy
-
AstraZenecaCompletedType 2 DiabetesUnited States, Mexico, Puerto Rico, Israel, Sweden, Italy, Philippines, Argentina
-
Novo Nordisk A/SWithdrawnDiabetes Mellitus, Type 2United States, Sweden, Austria, Finland
-
TakedaEli Lilly and CompanyCompletedDiabetes MellitusEstonia, Latvia, Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Lithuania, Netherlands, Norway, Poland, Slovakia, Sweden, Switzerland, United Kingdom
-
Assistance Publique - Hôpitaux de ParisIltoo PharmaCompletedType 1 DiabetesBelgium, France, Germany, Netherlands, Sweden, Switzerland
-
SanofiCompletedDiabetes Mellitus, Type 2Korea, Republic of, Russian Federation, Spain, Denmark, Canada, Germany, Ireland, Portugal, Australia, India, Turkey, Netherlands, Sweden, United Kingdom, Finland, Switzerland, Romania, Brazil, Serbia, Taiwan
-
TakedaCompleted
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Austria, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, Ecuador, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Italy, Malaysia, Mexico, Netherlands, Norway, Peru, Poland, Russian Federation and more
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Sweden, Norway, Germany, Australia
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2France, Germany, Slovakia, Sweden, Ukraine, United Kingdom
-
University of HelsinkiEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedDiabetes Mellitus, Type 1Spain, Luxembourg, Australia, Switzerland, Canada, Germany, Hungary, United States, Czechia, Estonia, Finland, Italy, Netherlands, Poland, Sweden
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, France, Denmark, Sweden, Netherlands, Belgium, Finland, Macedonia, The Former Yugoslav Republic of, Norway, Israel, Spain, Croatia, Slovenia, United Kingdom, Switzerland, Ireland
-
Medtronic DiabetesCompletedDiabetes Mellitus, Type 1Denmark, Spain, Belgium, Serbia, Sweden, Austria, France, Hungary, Israel, Italy, Lithuania, Poland, Slovakia, Slovenia
-
BayerActive, not recruitingType 2 Diabetes Mellitus | Chronic Kidney DiseaseJapan, Spain, Netherlands, Denmark, United States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland, Russian Federation, Denmark, Sweden, Macedonia, The Former Yugoslav Republic of, Norway, Croatia, France, Belgium, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Denmark, Sweden, Malaysia, Poland, Turkey, Finland, Australia, Thailand, Taiwan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany, Poland, Russian Federation, Spain, Sweden, Netherlands, Singapore, Malaysia, France, Croatia, Romania, United Kingdom, Hong Kong
-
BayerActive, not recruitingType 2 Diabetes Mellitus | Chronic Kidney DiseaseUnited States
-
Diamyd Medical ABRecruitingType 1 Diabetes MellitusCzechia, Spain, United States, Hungary, Netherlands, Estonia, Germany, Poland, Sweden
-
Medtronic DiabetesRecruitingType 1 DiabetesUnited States, Spain, New Zealand, Canada, France, Germany, Italy, Sweden, United Kingdom
-
Hoffmann-La RocheCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Germany, United Kingdom
-
Hoffmann-La RocheRoche Diabetes Care Deutschland GmbHCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Sweden, Finland, France, Norway
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Australia, Canada, Denmark, Netherlands, Sweden
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesSweden, France, Italy, Mexico, South Africa, Spain, Germany, Netherlands, Argentina, United Kingdom
-
Diamyd Therapeutics ABTerminatedType 1 Diabetes MellitusFrance, Germany, Finland, Italy, Netherlands, Slovenia, Spain, Sweden, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United Kingdom, Germany, Austria, Denmark, Norway, Sweden, Switzerland, Finland
-
Boehringer IngelheimCompletedHypertension | Diabetes Mellitus, Type 2United Kingdom, Denmark, Finland, Netherlands, Norway, Sweden